Literature DB >> 30982691

Social Profile of Patients Admitted for COPD Exacerbations. A Gender Analysis.

Sara Fernández-García1, Cristina Represas-Represas2, Alberto Ruano-Raviña1, Mar Mosteiro-Añón1, Cecilia Mouronte-Roibas1, Alberto Fernández-Villar3.   

Abstract

OBJECTIVE: To describe and compare from a gender perspective the social profile of patients admitted to a respiratory unit for COPD exacerbations (COPDE).
METHODOLOGY: A cross-sectional study in patients with serious COPDE in which demographic, clinical, and social data (economic situation, care, dependency for basic and instrumental activities, social risk, caregiver overload, use of social services) were collected using questionnaires and indices such as Barthel, Lawton-Brody, Zarit, Barber, and Gijón. A descriptive analysis was made of patients' social and healthcare situation, compared on the basis of gender.
RESULTS: We included 253 patients, aged 68.9±9.8years, 58 (23%) women, FEV1 42.1±14.2%, and Charlson index 1.8±0.9; 37.9% were active smokers. In total, 55.2% had an income of less than €800/month, 46.2% had some dependency for basic activities, and 89.3% for instrumental activities, 89% presented social fragility, while 64% were in a situation of social problem/risk; 49% had a caregiver, 83% in a non-formal arrangement, 90.9% of whom were women, with some overload reported by 69.2%. A total of 21.4% lived alone, and 22.9% had contacted social services. Women with COPDE are younger, smoke more actively, and have fewer comorbidities. They have more scant economic resources and assistance and are in a poorer socio-familiar situation, but they are less dependent for some activities.
CONCLUSIONS: The social profile of patients with serious COPDE admitted to respiratory units is very unfavorable, especially among women. These inequalities appear to go beyond differences in the expression of COPD, and are associated with gender.
Copyright © 2019 SEPAR. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  COPD; Chronicity; Cronicidad; Dependence; Dependencia; EPOC; Exacerbaciones; Exacerbations; Gender; Género; Social

Mesh:

Year:  2019        PMID: 30982691     DOI: 10.1016/j.arbres.2019.03.009

Source DB:  PubMed          Journal:  Arch Bronconeumol (Engl Ed)        ISSN: 0300-2896            Impact factor:   4.872


  5 in total

1.  Frequency and Associated Factors of Suicidal Ideation in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Carlos Roncero; Joselín Pérez; Jesús Molina; José Antonio Quintano; Ana Isabel Campuzano; Javier Pérez; Marc Miravitlles
Journal:  J Clin Med       Date:  2022-05-02       Impact factor: 4.964

2.  No gender-related bias in COPD diagnosis and treatment in Sweden: a randomised, controlled, case-based trial.

Authors:  Hamid Akbarshahi; Zainab Ahmadi; David C Currow; Jacob Sandberg; Zac Vandersman; Aaron Shanon-Honson; Magnus Ekström
Journal:  ERJ Open Res       Date:  2020-11-10

3.  Sociodemographic and Clinical Variables Related to the Overburden of the Informal Caregivers of Patients Hospitalized for Chronic Obstructive Pulmonary Disease Exacerbations.

Authors:  Sara Fernández-García; Cristina Represas-Represas; Alberto Ruano-Raviña; Alberto Fernández-García; Almudena González-Montaos; Ana Priegue-Carrera; Mónica Pérez-Ríos; Alberto Fernández-Villar
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-04-20

4.  Factors Related with Hospital Attendance and Mortality in Patients with COPD: A Case-Control Study in a Real-Life Setting.

Authors:  María Estrella López-Pardo; Cristina Candal-Pedreira; Luis Valdés-Cuadrado; Cristina Represas-Represas; Alberto Ruano-Ravina; Mónica Pérez-Ríos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-04-14

5.  [Do COPD patients lie about their smoking habit?]

Authors:  Virginia Almadana Pacheco; Cristina Benito Bernáldez; Estefanía Luque Crespo; Rafael Perera Louvier; Julio César Rodríguez Fernández; Agustín S Valido Morales
Journal:  Aten Primaria       Date:  2020-07-30       Impact factor: 1.137

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.